CHINA DAD’S GROWTH HORMONE INVESTMENT FOR DAUGHTER SPARKS DEBATE OVER SOCIETAL PRESSURE

In Changsha, Hunan province, a father named Li has begun paying about 6,000 yuan (roughly US$880) each month for growth hormone injections for his 12‑year‑old daughter, a decision that has ignited a heated online debate about height anxiety in China.

According to the South China Morning Post reporting on Dazhong Daily, the daughter’s growth rate was only two to three centimetres per year before the injections were started. While specific post‑treatment figures are not given, users on social media have shared both support for the intervention and concerns over its cost and the cultural pressure to be taller.

Height is increasingly viewed as a marker of success in Chinese society, prompting parents to pursue medical options. The controversy surrounding Li’s spending reflects a wider national conversation about the role of medical treatments in meeting societal expectations.

• Li spends ~6,000 yuan/month on growth hormone injections for his 12‑year‑old daughter.
• Pre‑treatment growth rate was 2–3 cm per year; post‑treatment gains are not quantified.
• The case has sparked an online debate about height anxiety and the economic burden of medical interventions.
• The discussion mirrors broader cultural pressures linking taller stature to career prospects and social status.

AI CONFIDENCE: HIGH • Built by DAMMNEWS AI from available News - South China Morning Post reporting and related coverage. Read the original source for full detail.